Health Highlights: Feb. 3, 2020

• Tweet
• Pin It

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

First Treatment for Peanut Allergy Approved by FDA

The first treatment for peanut allergy has been approved by the U.S. Food and Drug Administration.

Palforzia — a specially prepared peanut powder that’s consumed daily in small amounts that are gradually increased over months — helps children and teens better tolerate peanuts so that accidental exposure is less likely to cause a serious allergic reaction, the Associated Press reported.

Palforzia is not a cure, youngsters using the treatment still must avoid peanuts, and protection is lost if they stop taking the powder daily.

The treatment can cause side effects, including the risk of a severe allergic reaction. The FDA requires patients to take their first dose and each increased dose under supervision in a certified health center, and doctors and their patients must enroll in a special safety program, the AP reported.

Other treatments for peanut allergy are being developed, including a skin patch that’s up for FDA review.

—–

Facebook, Instagram Target False Coronavirus Information

Claims about fake cures and other misinformation about the new coronavirus will be removed by Facebook, says the company’s head of health, Kang-Xing Jin.

In a blog post published Thursday, Jin said Facebook will “remove content with false claims or conspiracy theories that have been flagged by leading global health organizations and local health authorities that could cause harm to people who believe them,” CNN reported.

That includes claims “related to false cures or prevention methods” or “that create confusion about health resources that are available,” Jin said.

Jin added that there will be increased fact-checking and monitoring on Instagram, which is owned by Facebook, CNN reported.

Copyright © 2025 HealthDay. All rights reserved.

• Tweet
• Pin It